Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study
Key facts
- Who runs it
- The University of New South Wales
- Where
- Berkeley, Boston, and New York, United StatesSee the 3 sitesAlso in 1 other country, 2 sites
- Trial code
- Status
- Recruiting
- People taking part
- 230 people, planned
- Started
- 21 Mar 2023
- Expected to end
- 31 Dec 2026
- Type of study
- Observational
- Treatments tested
- Vivior
- Record updated
- 12 December 2024
Who can take part
- Age
- 4 years to 14 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Aged 6 to below 14 years old
- Spherical equivalent myopic refractive error greater than -0.50 D
- Best corrected logMAR visual acuity of 0.1 or better in each eye for 6- to 14-year-old children, and 0.2 logMAR or better than in each eye for 4 and 5-year-old children (adjusted for age-related expectations)
- Good ocular and general health that would not preclude them from myopia control
- Competent enough in English to fully understand the participant information and consent form
- Willing to undergo treatment to slow myopia progression for one year
Who cannot take part
- Previous history of ocular surgery, trauma or chronic ocular disease that may affect their vision
- Ocular or systemic medication use which may interfere or interact with myopia treatment or ocular development
- Systemic or ocular conditions that may affect contact lens use (e.g. severe allergy) or refractive development (e.g. ptosis)
- Strabismus at distance or near, or amblyopia
- Child, parents or guardians not willing to comply with treatment and/or follow-up schedule and planning to migrate or move during the one-year study duration
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 4 and 14 years old?
Where in United States
Also in 1 other country, 2 sites
- School of Optometry, University of California, BerkeleyBerkeley, United StatesContact: Pauline Kang, PhDNo longer taking part
- New England College of OptometryBoston, United StatesContact: Fuensanta Vera-Diaz, PhDTaking people
- State University of New York (SUNY), College of OptometryNew York, United StatesContact: Xiaoying Zhu, PhDNot yet recruiting
About the trial
What the trial wants to find out
Currently, optical and pharmacological interventions have been developed to prevent the progression of childhood myopia. However, no myopia control strategy has been shown to have complete efficacy in controlling myopia progression in children. One possible reason is that risk factors contributing to the development of myopia were not controlled in previous clinical studies including time outdoors and near vision behaviour. This study aims to quantify time spent outdoors and near vision behavior in myopic children and its impact on myopia control efficacy. The outcomes of this study will guide clinicians on risk management and improve responses to existing treatments for progressive myopia.
Treatments tested
- Vivior
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Multicenter Study of Near Vision Behavior and Outdoor Time in Children Undergoing Myopia Control
- Criteria questions
- Built from NCT06119243, who can take part
- Record updated
- 12 December 2024